Not to split hairs and it would not be my key criteria but the acquisition is accretive not dilutive.
They are buying ARR at 4.1X and the company is cash flow neutral due to services and to earn the earn out, the acquisition looks cash flow positive.
- Forums
- ASX - By Stock
- LVT
- Ann: Investor Presentation - CYCL Acquisition
Ann: Investor Presentation - CYCL Acquisition, page-5
-
-
- There are more pages in this discussion • 127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LVT (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.474M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LVT (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online